Skip to main content
Top
Published in: Tumor Biology 1/2011

01-02-2011 | Research Article

1H-NMR-based metabolomics of tumor tissue for the metabolic characterization of rat hepatocellular carcinoma formation and metastasis

Authors: Juan Wang, Shu Zhang, Zongfang Li, Jun Yang, Chen Huang, Rongrui Liang, Zhongwei Liu, Rui Zhou

Published in: Tumor Biology | Issue 1/2011

Login to get access

Abstract

The high mortality figures for hepatocellular carcinoma (HCC) are mostly due to high recurrence and metastasis rates. However, the metabolic characteristics of HCC metastasis have not been studied extensively. In this study, we attempted to elucidate the metabolite profile of HCC formation and metastasis through proton nuclear magnetic resonance (1H-NMR)-based metabolomics. We first established a hepatocellular carcinoma with lung metastasis (HLM) rat model by exposure to diethylnitrosamine. Fifteen rats were then divided into three groups based on pathologic changes: HCC, HLM, and controls. The metabolite profiles of extracts from tumor tissue were obtained using high-resolution 1H-NMR. One-way ANOVA was used to compare the metabolite levels among the three groups. Multivariate statistical analysis (specifically, unsupervised principal components analysis and supervised partial least squares discriminant analysis (PLS-DA)) were used for HCC and HLM metabolite profiling and data interpretation. PLS-DA models could discern HCC or HLM rats from normal (control) rats. Tumor tissue from HLM showed changes in glucose, lactate, choline, lipids, and some amino acids such as glycine. The results of this pilot study suggest that alterations in glycolysis and the metabolism of glycine and choline occur during HCC invasion and metastasis.
Literature
3.
go back to reference Kawano Y, Sasaki A, Kai S, Endo Y, Iwaki K, Uchida H, et al. Prognosis of patients with intrahepatic recurrence after hepatic resection for hepatocellular carcinoma: a retrospective study. Eur J Surg Oncol. 2009;35:174–9. doi:10.1016/j.ejso.2008.01.027.PubMed Kawano Y, Sasaki A, Kai S, Endo Y, Iwaki K, Uchida H, et al. Prognosis of patients with intrahepatic recurrence after hepatic resection for hepatocellular carcinoma: a retrospective study. Eur J Surg Oncol. 2009;35:174–9. doi:10.​1016/​j.​ejso.​2008.​01.​027.PubMed
4.
go back to reference Song PM, Bao HM, Yu YB, Xue Y, Yun D, Zhang Y, et al. Comprehensive profiling of metastasis-related proteins in paired hepatocellular carcinoma cells with different metastasis potentials. Proteomics Clin Appl. 2009;3:841–52. doi:10.1002/prca.200780131.CrossRefPubMed Song PM, Bao HM, Yu YB, Xue Y, Yun D, Zhang Y, et al. Comprehensive profiling of metastasis-related proteins in paired hepatocellular carcinoma cells with different metastasis potentials. Proteomics Clin Appl. 2009;3:841–52. doi:10.​1002/​prca.​200780131.CrossRefPubMed
8.
go back to reference Nicholson JK, Lindon JC, Holmes E. ‘Metabolomics’: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica. 1999;29:1181–9. doi:10.1080/004982599238047.CrossRefPubMed Nicholson JK, Lindon JC, Holmes E. ‘Metabolomics’: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica. 1999;29:1181–9. doi:10.​1080/​004982599238047.CrossRefPubMed
9.
go back to reference Ma YL, Qin HL, Liu WJ, Peng JY, Huang L, Zhao XP, et al. Ultra-high performance liquid chromatography–mass spectrometry for the metabolomic analysis of urine in colorectal cancer. Dig Dis Sci. 2009;54:2655–62. doi:10.1007/s10620-008-0665-4.CrossRef Ma YL, Qin HL, Liu WJ, Peng JY, Huang L, Zhao XP, et al. Ultra-high performance liquid chromatography–mass spectrometry for the metabolomic analysis of urine in colorectal cancer. Dig Dis Sci. 2009;54:2655–62. doi:10.​1007/​s10620-008-0665-4.CrossRef
11.
go back to reference Yang Y, Li C, Nie X, Feng X, Chen W, Yue Y, et al. Metabonomic studies of human hepatocellular carcinoma using high-resolution magic-angle spinning 1H NMR spectroscopy in conjunction with multivariate data analysis. J Proteome Res. 2007;6:2605–14. doi:10.1021/pr070063h.CrossRefPubMed Yang Y, Li C, Nie X, Feng X, Chen W, Yue Y, et al. Metabonomic studies of human hepatocellular carcinoma using high-resolution magic-angle spinning 1H NMR spectroscopy in conjunction with multivariate data analysis. J Proteome Res. 2007;6:2605–14. doi:10.​1021/​pr070063h.CrossRefPubMed
15.
go back to reference Sivaramakrishnan V, Niranjali Devaraj S. Morin regulates the expression of NF-κB-p65, COX-2 and matrix metalloproteinases in diethylnitrosamine induced rat hepatocellular carcinoma. Chemi Biol Interact. 2009;180:353–9. doi:10.1016/j.cbi.2009.02.004.CrossRef Sivaramakrishnan V, Niranjali Devaraj S. Morin regulates the expression of NF-κB-p65, COX-2 and matrix metalloproteinases in diethylnitrosamine induced rat hepatocellular carcinoma. Chemi Biol Interact. 2009;180:353–9. doi:10.​1016/​j.​cbi.​2009.​02.​004.CrossRef
16.
18.
go back to reference Jose JK, Kuttan R, Bhattacharya RK. Effect of Emblica officinalis extract on hepatocarcinogenesis and carcinogen metabolism. J Clin Biochem Nutr. 1998;25:31–9. Jose JK, Kuttan R, Bhattacharya RK. Effect of Emblica officinalis extract on hepatocarcinogenesis and carcinogen metabolism. J Clin Biochem Nutr. 1998;25:31–9.
20.
go back to reference Garrod S, Bollard ME, Nicholls AW, Connor SC, Connelly J, Nicholson JK, et al. Integrated metabonomic analysis of the multiorgan effects of hydrazine toxicity in the rat. Chem Res Toxicol. 2005;18:115–22. doi:10.1021/tx0498915.CrossRefPubMed Garrod S, Bollard ME, Nicholls AW, Connor SC, Connelly J, Nicholson JK, et al. Integrated metabonomic analysis of the multiorgan effects of hydrazine toxicity in the rat. Chem Res Toxicol. 2005;18:115–22. doi:10.​1021/​tx0498915.CrossRefPubMed
23.
go back to reference Montcourrier P, Silver I, Farnoud R, Bird I, Rochefort H. Breast cancer cells have a high capacity to acidify extracellular milieu by a dual mechanism. Clin Exp Metastasis. 1997;15:382–92.CrossRefPubMed Montcourrier P, Silver I, Farnoud R, Bird I, Rochefort H. Breast cancer cells have a high capacity to acidify extracellular milieu by a dual mechanism. Clin Exp Metastasis. 1997;15:382–92.CrossRefPubMed
24.
go back to reference Schlappack OK, Zimmermann A, Hill RP. Glucose starvation and acidosis: effect on experimental metastatic potential, DNA content and MTX resistance of murine tumour cells. Br J Cancer. 1991;64:663–70.PubMed Schlappack OK, Zimmermann A, Hill RP. Glucose starvation and acidosis: effect on experimental metastatic potential, DNA content and MTX resistance of murine tumour cells. Br J Cancer. 1991;64:663–70.PubMed
25.
go back to reference Martinez-Zaguilan R, Seftor EA, Seftor RE, Chu YW, Gillies RJ, Hendrix MJ. Acidic pH enhances the invasive behavior of human melanoma cells. Clin Exp Metastasis. 1996;14:176–86. doi:10.1007/BF00121214.CrossRefPubMed Martinez-Zaguilan R, Seftor EA, Seftor RE, Chu YW, Gillies RJ, Hendrix MJ. Acidic pH enhances the invasive behavior of human melanoma cells. Clin Exp Metastasis. 1996;14:176–86. doi:10.​1007/​BF00121214.CrossRefPubMed
26.
go back to reference Morse DL, Carroll D, Day S, Gray H, Sadarangani P, Murthi S, et al. Characterization of breast cancers and therapy response by MRS and quantitative gene expression profiling in the choline pathway. NMR Biomed. 2009;22:114–27. doi:10.1002/nbm.1318.CrossRefPubMed Morse DL, Carroll D, Day S, Gray H, Sadarangani P, Murthi S, et al. Characterization of breast cancers and therapy response by MRS and quantitative gene expression profiling in the choline pathway. NMR Biomed. 2009;22:114–27. doi:10.​1002/​nbm.​1318.CrossRefPubMed
27.
29.
go back to reference Yanagida O, Kanai Y, Chairoungdua A, Kim DK, Segawa H, Nii T, et al. Human l-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines. Biochim Biophys Acta. 2001;1514:291–302. doi:10.1016/S0005-2736(01)00384-4.CrossRefPubMed Yanagida O, Kanai Y, Chairoungdua A, Kim DK, Segawa H, Nii T, et al. Human l-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines. Biochim Biophys Acta. 2001;1514:291–302. doi:10.​1016/​S0005-2736(01)00384-4.CrossRefPubMed
31.
go back to reference Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, et al. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature. 2009;457:910–4. doi:10.1038/nature07762.CrossRefPubMed Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, et al. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature. 2009;457:910–4. doi:10.​1038/​nature07762.CrossRefPubMed
Metadata
Title
1H-NMR-based metabolomics of tumor tissue for the metabolic characterization of rat hepatocellular carcinoma formation and metastasis
Authors
Juan Wang
Shu Zhang
Zongfang Li
Jun Yang
Chen Huang
Rongrui Liang
Zhongwei Liu
Rui Zhou
Publication date
01-02-2011
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 1/2011
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-010-0116-7

Other articles of this Issue 1/2011

Tumor Biology 1/2011 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine